Key Insights

Highlights

Success Rate

60% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

10.5%

2 terminated out of 19 trials

Success Rate

60.0%

-26.5% vs benchmark

Late-Stage Pipeline

21%

4 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results60% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (10)
P 1 (1)
P 2 (1)
P 3 (3)
P 4 (1)

Trial Status

Not Yet Recruiting6
Unknown4
Completed3
Recruiting2
Terminated2
Suspended1

Trial Success Rate

60.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT07446296Not ApplicableRecruiting

Kidney Transplant Improvement Through New Exercise Training to Increase Capacity

NCT06741072Phase 1SuspendedPrimary

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

NCT07260292Not ApplicableCompleted

KPs Supplement for Inflammation, Oxidative Stress and Lipid Abnormalities in CKD Patients.

NCT07221604Not ApplicableNot Yet RecruitingPrimary

The Agenda-Setting for Kidney Disease Open Pilot Trial

NCT05797506Phase 2Active Not Recruiting

Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease

NCT07024953Not ApplicableNot Yet RecruitingPrimary

The Agenda-Setting for Kidney Disease Trial

NCT07027774Phase 4Not Yet RecruitingPrimary

Effect of Henagliflozin on Renal Outcomes in Non-dialysis Patients With Advanced Chronic Kidney Disease : A Multicenter Prospective, Randomized Controlled Trial(HERO -aCKD)

NCT06956872Not ApplicableNot Yet Recruiting

Clinical Effectiveness of MyNutriKidney®

NCT06799936Not ApplicableRecruitingPrimary

A Communication-Priming Intervention to Improve Shared Decision-Making Between Older Adults With Advanced CKD and Clinicians

NCT06820372Not Yet RecruitingPrimary

Improving Medication Safety for Kidney Disease with a Digital Drug Dosing Tool in Nova Scotia Community Pharmacy Practice.

NCT06760650Not ApplicableNot Yet RecruitingPrimary

Fluorescein Angiography in Patients With Diabetes and Chronic Kidney Disease

NCT05225454Unknown

The Life Style Patterns and the Development Trend of Chronic Diseases in Healthy and Sub-healthy Groups Were Analyzed by Using Data-mining Techniques

NCT04171778Not ApplicableTerminated

Effects of Whole Food, Plant-Based Nutrition on Chronic Kidney Disease With Proteinuria

NCT04012957Phase 3Completed

Desidustat in the Treatment of Anemia in CKD

NCT03242018Phase 3Completed

A Study to Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control

NCT03311321Not ApplicableUnknown

Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients

NCT02039167Not ApplicableTerminated

Left Atrial Appendage Occlusion vs. Usual Care in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease

NCT01509716Unknown

Assessing Perceived Versus Actual Knowledge and Quality of Life in Pre-Dialysis Chronic Kidney Disease (CKD) Patients

NCT01709994Phase 3UnknownPrimary

Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients

Showing all 19 trials

Research Network

Activity Timeline